Inventor
KONG JAE YANG
KR14 patents
⚠️ This page may combine multiple inventors who share the name “KONG JAE YANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KOREA RES INST CHEM TECH
7 patentsUS5990126ANov 23, 1999
Quinolinic sulfide derivatives acting as NMDA receptor antagonists and process for preparation thereof
KOREA RES INST CHEM TECH47 citations90
US7662810B2Feb 16, 2010
2-arylmethylazetidine carbapenem derivatives and preparation thereof
KOREA RES INST CHEM TECH2 citations60
US7915405B2Mar 29, 2011
2,4-disubstituted-5-aminocarbonyl-1,3-thiazole derivatives for therapeutic agent of antiinflammatory disease, method thereof for preparation, therapeutic agent for antiinflammatory disease induced by SPC activity containing the same
KOREA RES INST CHEM TECH2 citations59
US5973201AOct 26, 1999
Phenylacetamide derivatives
KOREA RES INST CHEM TECH4 citations59
US7009053B2Mar 7, 2006
Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
KOREA RES INST CHEM TECH6 citations57
US8372844B2Feb 12, 2013
Piperazinyl-propyl-pyrazole derivatives as dopamine D4 receptor antagonists, and pharmaceutical compositions containing the same
KOREA RES INST CHEM TECH0 citations50
US7078407B2Jul 18, 2006
4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them
KOREA RES INST CHEM TECH0 citations36
KOREA INST SCI & TECH
4 patentsUS6723724B2Apr 20, 2004
Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
KOREA INST SCI & TECH17 citations82
US6716857B2Apr 6, 2004
Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors
KOREA INST SCI & TECH9 citations71
US6759419B2Jul 6, 2004
Pyrrolidinone derivatives, their preparation and pharmaceutical composition comprising the same
KOREA INST SCI & TECH8 citations69
US6673800B2Jan 6, 2004
4,5,-dihydroisoxazolylakylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
KOREA INST SCI & TECH3 citations61